カテゴリ： GlobalData, 医療/バイオ

悪性中皮腫治療薬の世界市場：治験レビュー

◆英語タイトル：Malignant Mesothelioma Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0079
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年12月
◆ページ数：383
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥270,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥540,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥810,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Malignant Mesothelioma Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Malignant Mesothelioma Global Clinical Trials Review, H2, 2019″ provides an overview of Malignant Mesothelioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Mesothelioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Malignant Mesothelioma to Oncology Clinical Trials 22
Clinical Trials by Phase in E7 Countries 24
Clinical Trials in E7 Countries by Trial Status 25
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Malignant Mesothelioma Therapeutics Clinical Trials 35
Prominent Drugs 37
Latest Clinical Trials News on Malignant Mesothelioma 38
Nov 07, 2019: MaxCyte to present at BIO-Europe 2019 38
Oct 24, 2019: MaxCyte advances phase I clinical trial of lead CARMA mRNA-based Cell Therapy to third cohort of patients 38
Sep 30, 2019: MaxCyte Presents Updates on First-in-class CARMA Platform at Upcoming Meetings 38
Sep 30, 2019: Mesothelioma trial suggests immunotherapy as an alternative to chemotherapy 39
Clinical Trial Profile Snapshots 41
Appendix 395
Abbreviations 395
Definitions 395
Research Methodology 396
Secondary Research 396
About GlobalData 397
Contact Us 397
Disclaimer 397
Source 398

List of Tables
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Region, 2019* 8
Malignant Mesothelioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Malignant Mesothelioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Malignant Mesothelioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Malignant Mesothelioma Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Malignant Mesothelioma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Malignant Mesothelioma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, G7 Countries (%), 2019* 18
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, E7 Countries (%), 2019* 23
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Phase, 2019* 26
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Malignant Mesothelioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Malignant Mesothelioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 32
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37

List of Figures
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Malignant Mesothelioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Malignant Mesothelioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Malignant Mesothelioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Malignant Mesothelioma Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Malignant Mesothelioma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Malignant Mesothelioma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, G7 Countries (%), 2019* 17
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Malignant Mesothelioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Malignant Mesothelioma to Oncology Clinical Trials, E7 Countries (%), 2019* 22
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
Malignant Mesothelioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26
Malignant Mesothelioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27
Malignant Mesothelioma Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Malignant Mesothelioma Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Malignant Mesothelioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 32
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 33
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 35
Malignant Mesothelioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 37
GlobalData Methodology 396

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[悪性中皮腫治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 悪性神経膠腫治療薬の世界市場：治験レビュー
    GDT20FB0001 / GlobalData / 2019年12月 / ...Malignant Glioma Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Malignant Glioma Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  2. 菌血症治療薬の世界市場：治験レビュー
    GDT20FB0050 / GlobalData / 2019年12月 / ...Bacteremia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bacteremia Global Clinical Trials Review, H2, 2019" provides an overview of Bacteremia clinical trials scenario. This report provides top line data relating to the clinical trials on Bacteremia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports...
  3. 高脂血症治療薬の世界市場：治験レビュー
    GDT20FB0099 / GlobalData / 2020年1月 / ...Hyperlipidemia Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H1, 2020" provides an overview of Hyperlipidemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  4. 開放隅角緑内障治療薬の世界市場：治験レビュー
    GDT20FB0115 / GlobalData / 2020年1月 / ...Open-Angle Glaucoma Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2020" provides an overview of Open-Angle Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  5. アテローム性動脈硬化治療薬の世界市場：治験レビュー
    GDT20FB0063 / GlobalData / 2019年12月 / ...Atherosclerosis Global Clinical Trials Review, H2, 2019.... Summary GlobalData's clinical trial report, “Atherosclerosis Global Clinical Trials Review, H2, 2019" provides an overview of Atherosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Atherosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  6. 脱毛症治療薬の世界市場：治験レビュー
    GDT20FB0025 / GlobalData / 2019年12月 / ...Alopecia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Alopecia Global Clinical Trials Review, H2, 2019" provides an overview of Alopecia clinical trials scenario. This report provides top line data relating to the clinical trials on AlopeciaReport includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated...
  7. 高尿酸血症治療薬の世界市場：治験レビュー
    GDT20FB0121 / GlobalData / 2020年1月 / ...Hyperuricemia Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H1, 2020" provides an overview of Hyperuricemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  8. サルコペニア治療薬の世界市場：治験レビュー
    GDT20FB0055 / GlobalData / 2019年12月 / ...Sarcopenia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Sarcopenia Global Clinical Trials Review, H2, 2019" provides an overview of Sarcopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Sarcopenia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports...
  9. 自閉症治療薬の世界市場：治験レビュー
    GDT20FB0029 / GlobalData / 2019年12月 / ...Autism Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Autism Global Clinical Trials Review, H2, 2019" provides an overview of Autism clinical trials scenario. This report provides top line data relating to the clinical trials on Autism Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  10. 酒さ治療薬の世界市場：治験レビュー
    GDT20FB0041 / GlobalData / 2019年12月 / ...Rosacea Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Rosacea Global Clinical Trials Review, H2, 2019" provides an overview of Rosacea clinical trials scenario. This report provides top line data relating to the clinical trials on Rosacea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆